相关实验视频
Updated: Jun 16, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
826
在创伤患者中抗血素III水平和结果
David H Farrell1, Keeley M McConnell1, Jevgenia Zilberman-Rudenko1
1Donald D. Trunkey Center for Civilian and Combat Casualty Care, Oregon Health & Science University, Portland.
JAMA network open
|August 15, 2024
概括
创伤患者的抗血素III缺乏与更糟糕的结果有关,包括增加出血和死亡率. 监测抗血素III水平可能有助于对创伤患者的风险评估.
科学领域:
- 创伤和重症监护医学 创伤和重症监护医学
- 凝血和静血研究 凝血和静血研究
- 生物化学和分子生物学
背景情况:
- 创伤患者经常经历复杂的凝血病,其特点是出血和血栓形成.
- 抗血素III (ATIII) 是血凝固的关键调节剂,在创伤患者中观察到的缺乏率很高.
- 了解ATIII在创伤中的作用对于管理血栓塞瘤并发症至关重要.
研究的目的:
- 调查抗血素III活性水平与创伤患者中血小板出血并发症的发生之间的关联.
- 确定ATIII缺乏是否与特定的不良结果相关,如出血,深静脉血栓 (DVT) 和死亡率.
- 评估ATIII水平在预测创伤后患者结果方面的临床相关性.
主要方法:
- 一项前性队列研究,涉及292名创伤患者入院于一级创伤中心.
- 数据收集包括对抗血III活性的量化,以及对出血,DVT,肺栓塞和死亡率的监测.
- 患者接受治疗后6天的随访,对收集的数据进行了分析.
主要成果:
- 抗素III缺乏与无呼吸器,无住院和无ICU日数显著减少有关.
- 患有ATIII缺乏症的患者表现出更高的渐进性内出血和血小板狭窄的发病率.
- 虽然与DVT没有显著的关联,但患有DVT的患者的ATIII水平较低.
结论:
- 在创伤患者中,抗血素III缺乏与增加受伤严重程度,出血和死亡率有关.
- 这些发现表明,抗血素III水平可能是创伤护理风险评估的有价值生物标志物.
- 进一步的研究可能会阐明调节创伤患者ATIII活性的治疗潜力.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Disorders of Hemostasis
758
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
758
Coagulation
5.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.7K
Extrinsic and Intrinsic Pathways of Hemostasis
6.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.6K
Clot Retraction and Fibrinolysis
5.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.0K
Introduction to Hemostasis
6.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.8K

